Madeline Colli

When you think of cannabis, you probably don’t think of horses or the potential medicinal benefit to animals. However, the cannabinoids found in cannabis have been shown to provide similar benefits in animals that are noted with human patients. In this interview, Emma Davis, founder of Mikko’s Choice, delves into how some cannabinoids—such as tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinolic acid (THCA)—have provided medicinal benefits to horses. Davis also discusses her mustang, Mikko, who inspired her to launch her own cannabis and hemp product brand.

Don't miss this Noid Factoid from Dr. Reggie Gaudino, VP of R&D at Front Range Biosciences.

For more than 20 years, Americans for Safe Access (ASA), the largest national member-based organization of patients, medical professionals, scientists, and citizens, have been advocating for cannabis to be seen as a form of medicine. Here, Steph Sherer and Debbie Churgai of ASA discuss the importance of medical cannabis and how advocacy will light the way forward.

When she was three-and-a-half years old, Brooklyn Hall was diagnosed with anaplastic ependymoma, class 3, a rare and unique form of brain cancer. Here, her mother Meghan Hall shares how Brooklyn’s prognosis drastically changed with the help of Rick Simpson Oil.

In a recent announcement, Major League Baseball announced a sponsorship deal with cannabidiol (CBD) company Charlotte’s Web.

Dr. Anthony Macherone of Agilent Technologies shares what he learned at Cannabis Science Conference East 2022.

Dr. Anthony Macherone of Agilent Technologies discusses what he hopes to see change in the future regarding cannabis regulations and testing guidelines.

Dr. Stephen Barnhill, founder, chairman, and CEO of Apollon Formularies, plc., explained to Cannabis Science Conference East 2022 attendees, his findings on how cannabis and mushrooms can be the ultimate weapon in the war against cancer.

Dr. Anthony Macherone of Agilent Technologies discusses some of the unique challenges when developing testing methods for cannabis products.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.

A recent study disclosed how younger generations are experimenting with cannabis and hallucinogenic use at the highest levels according to data from previous years.

When a patient isn’t able to access the care or medication that they need in their home country, they aren’t left with much of a choice but to travel to a country that will give them the treatment they need. In part II of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), continues discussing her journey to health, the broken healthcare system hurting medical cannabis patients in the US, and what needs to change to make access better for patients.

In early June 2022, the New York State Senate approved a bill which mandated public health insurance programs to cover medical cannabis expenses and defined how private insurers are allowed to handle these expenses as well (1).

What happens when traditional medicine fails a patient? When all recourses have been tried and the patient still suffers? In part I of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), takes us through her journey from a medical professional in the healthcare industry to a brain injury survivor. Lawley also describes the medical cannabis industry from a patient perspective, learning about the medicinal properties of the plant, and finding what ways cannabis could be beneficial to her symptoms.

Otha Smith III shares his personal journey with medical cannabis and how it led to founding the Tetragram app.

When it comes to cannabis cultivation, growers have their own methods on how to get the best products from their plants. Through using different soils, irrigation practices, lighting, and other approaches, each item plays an important role in how the plant matures. In this interview, David Cohen, CEO of Fluence, discusses the rise in LED lighting methods and how it can be the best tool for the industry.

Nurse Practitioner Me Fuimaono-Poe discusses how becoming an advocate and assisting with legislation are the best tools to help your state, community, and yourself gain access to cannabis and help others.

Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.

The science of cannabis is in its beginning stages and has a large opportunity for growth advancement. Market Manager for Cannabis for Shimadzu, Eberhardt Kuhn, Ph.D., will be presenting two talks for both the hemp and analytical tracks, “Starting with the Roots - the Many Uses of Hemp” and “Delta Dawn - the Next Generation of Cannabinoids?” If you are interested in exploring hemp or cannabidiol (CBD) and other cannabinoids, check out both of these presentations to learn more! In this interview, Kuhn also discusses his interests in the cannabis industry and other presenters at the Cannabis Science Conference (CSC) West taking place in Long Beach, California from May 18–20, 2022.

Martha Hernández, a scientist at CloudLIMS, discusses the challenges of working in the cannabis industry, navigating quality assurance (QA) and quality control (QC) expectations, and her upcoming lectures at the upcoming Cannabis Science Conference West.

As time passes and more research comes to light regarding COVID-19, additional research is also needed for cannabis and its various cannabinoids. Through new data, cannabis has shown that it has more to offer than the stigma it has been clouded by. In this interview, Inesa Ponomariovaite, founder of Nesas Hemp and a holistic health coach, discusses the untapped medicinal properties of cannabidiolic acid (CBDA) and cannabigerolic acid (CGBA) for COVID-19 prevention and treatment and why CBDA is the top cannabinoid.

A recent research study in the Journal of Nature Products showed that cannabis compounds prevented the COVID-19 virus from penetrating healthy human cells.

Recently The Hemp Mine, LLC announced their joint collaboration with Clemson University, to create the Cannabis Research Coalition (CRC).

Peter Grinspoon, MD, a primary care physician at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School, shares his knowledge on medical cannabis, issues facing the industry, and hopes for the future.

Bryan Buckley, the president and CEO of Helmand Valley Growers Company (HVGC), is set to make a big change for the veteran community and is using his company to push research and access forward for his comrades.

Providing cannabis is just one of the many ways that Jason Hanley, owner of CARE Waialua, has set out to help veterans. In this interview, you will learn the amazing things going on at this cannabis farm in Hawaii.

Learn more about TAPS and how you can get involved.

Gb Sciences, recently announced positive results from a study of its cannabinoid-containing mixtures as a potential treatment for cytokine release syndrome (CRS). With the high rate of transmission of the Omicron variant in multiple countries, Gb Sciences team are working to move quickly through the development stages for this novel CRS therapy.

Realm of Caring is a 501c3 nonprofit organization that conducts their own research such as their endeavor of the Observational Research Registry (ORR) study. They are also involved in advocacy work to help battle the stigma surrounding cannabis. In this interview, Nicolas Schlienz, PhD, Research Director at Realm of Caring, discusses the organization’s efforts to educate the public and healthcare professionals on the research being done on medical cannabis.

CRATIV announced recently a partnership with One Tree Planted to aid in the restoration and reforestation of natural areas impacted by the devasting fires across the US and Canada.